Future research in EGPA should be targeted at clarifying its pathophysiology and the therapies best suited to achieve optimal outcomes. The diagnostic landscape of eosinophilic granulomatosis with ...
Red blood cell antibody seroconversion in pregnancy was uncommon, with a rate of 0.26%. Clinically significant antibody seroconversion of red blood cells during pregnancy is rare, occurring in only ...
The study revealed that the 2022 criteria demonstrated high sensitivity and specificity for EGPA, low sensitivity and high specificity for GPA, and high sensitivity and low specificity for MPA, with ...
(Getty Images) The SPPB is a validated tool to predict morbidity and mortality, often among older adults. After adjusting for covariates, each 1-point increase in SPPB score was associated with a 13% ...
Because acute chest syndrome in SCD can be life-threatening, it is important for physicians to recognize this disorder and initiate treatment accordingly. Acute chest syndrome (ACS) is one of the most ...
To treat my Chronic inflammatory demyelinating polyneuropathy (CIDP), I was given a 5-day induction dose of intravenous immunoglobulin (IVIG). The first dose went well, but the second day was awful, ...
In NMOSD, satralizumab is believed to be more effective in preventing relapse of optic neuritis than of myelitis. Satralizumab was safe and effective at preventing relapses of optic neuritis in ...
The varied manifestations of IgG4-RD can make the diagnosis challenging, but prompt treatment can resolve symptoms and prevent recurrence. A new case has been reported of a patient with immunoglobulin ...
Man with hand on his chest, seeing doctor Over time, the number of new ATTR-CM diagnoses with no heart failure symptoms progressively increased. Symptomatic heart failure developed in 50% of patients ...
Primary myelofibrosis is a rare bone marrow blood cancer that disrupts the production of blood cells. This results in extramedullary hematopoiesis in other parts of the body, most notably the spleen, ...
Efgartigimod alfa and hyaluronidase-qvfc (Vyvgart Hytrulo ®) precision therapy has been approved by China’s National Medical Products Administration (NMPA) to treat chronic inflammatory demyelinating ...
The authors observed no causal relationship between CIDP or Gillian Barre syndrome (GBS) and the presence of any of the 22 antibody immune responses. The presence of herpesvirus antibodies did not ...